1. Introduction

Digital Pathogen Governance Accountability is an emerging area of biotechnology law, biosecurity law, public-health regulation, artificial intelligence governance, and digital-data protection.

It concerns the legal responsibility of governments, biotechnology companies, research institutions, laboratories, healthcare organizations, and digital-platform operators for the development, monitoring, storage, analysis, transmission, and control of pathogen-related digital information and technologies.

Digital pathogen governance involves technologies such as:

AI-powered pathogen detection and genomic surveillance.

Digital databases containing viral and bacterial genome sequences.

Cloud-based storage of pathogen research information.

Computational models predicting infectious-disease outbreaks.

Digital laboratory information-management systems.

Automated systems for identifying dangerous biological agents.

International platforms sharing pathogen samples and genomic information.

AI systems supporting vaccine and drug development.

The central legal question is:

Who is legally accountable when a digital pathogen-management system causes, enables, conceals, or fails to prevent biological harm?

For example, suppose a biotechnology laboratory uses an AI platform to analyse dangerous pathogen sequences. Due to inadequate cybersecurity, unauthorized individuals obtain access to sensitive information. Alternatively, an AI surveillance system fails to identify an emerging outbreak, resulting in widespread infection.

Accountability may arise through negligence, statutory violations, constitutional rights, data-protection failures, environmental liability, public-health legislation, contractual obligations, or international biosecurity commitments.

The subject is particularly important in India, Australia, and international law because pathogen information increasingly crosses national borders while regulatory responsibility remains divided between different institutions.

2. Meaning and Scope of Digital Pathogen Governance Accountability

The concept has three interconnected elements.

A. Digital pathogen governance

This involves the legal and institutional regulation of digital systems used to collect, process, store, exchange, and analyse biological information.

B. Pathogen accountability

This identifies the individuals and institutions responsible for preventing biological risks, maintaining laboratory safety, protecting sensitive information, and responding to outbreaks.

C. Governance accountability

This requires transparent decision-making, independent supervision, proper documentation, regulatory audits, effective remedies, and consequences for misconduct.

Together, these elements establish a system in which digital pathogen technologies cannot operate without identifiable legal responsibility.

3. Major Areas of Legal Accountability

A. Accountability for AI-based pathogen surveillance

AI systems can analyse genomic sequences, epidemiological information, and laboratory results to identify possible biological threats.

Legal accountability arises when:

An algorithm incorrectly classifies a dangerous pathogen.

A surveillance platform fails to detect an outbreak.

A government agency ignores credible algorithmic warnings.

An AI system generates misleading public-health recommendations.

A private technology provider fails to disclose significant system limitations.

Potential liability may involve negligence, administrative law, professional misconduct, and breach of statutory duties.

An important principle is that the use of AI does not automatically transfer legal responsibility from the human institution to the algorithm.

B. Laboratory cybersecurity accountability

Digital laboratories maintain sensitive information relating to pathogens, genetic sequences, research activities, and experimental results.

Organizations may face legal consequences where they fail to implement reasonable security measures.

Relevant failures include:

Unauthorized access to biological databases.

Inadequate authentication and access controls.

Improper handling of sensitive genomic information.

Failure to report qualifying cybersecurity incidents.

Negligent management of laboratory information systems.

Responsibility may extend to laboratory directors, institutional management, technology vendors, data processors, and government regulators, depending on their respective duties and conduct.

C. Accountability for digital pathogen-data breaches

Pathogen-related digital information may contain personal, genetic, epidemiological, and institutional information.

A breach may create two different forms of legal harm:

Privacy harm: Unauthorized disclosure of identifiable health or genetic information.

Biosecurity harm: Unauthorized access to sensitive biological research information.

These risks must be assessed separately because privacy protection and biological security are related but legally distinct regulatory objectives.

D. Cross-border pathogen-data sharing

International pathogen databases enable scientists and public-health authorities to exchange information.

However, disputes can arise concerning:

Ownership and permitted use of pathogen-related information.

Consent and benefit-sharing.

Confidentiality and intellectual property.

National security restrictions.

Access to vaccines and medical countermeasures.

Responsibility for unauthorized international disclosure.

The World Health Organization's International Health Regulations and the Convention on Biological Diversity provide important international legal context.

4. Important Case Laws and Judicial Principles

There is no universally recognised independent cause of action called the Digital Pathogen Governance Accountability Doctrine. The following decisions establish legal principles that can be applied to digital pathogen systems.

A. Indian case laws

1. M.C. Mehta v. Union of India (1987) 1 SCC 395 – Absolute liability

Facts: The case arose from the leakage of oleum gas from an industrial establishment in Delhi.

Judgment: The Supreme Court established the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities.

Relevance:

Hazardous biological research institutions must take exceptional precautions.

An enterprise cannot avoid responsibility merely by delegating safety operations to contractors.

Digital monitoring failures may form part of the circumstances establishing institutional negligence or failure to meet safety obligations.

The judgment provides an important foundation for assigning responsibility where hazardous biological operations cause harm.

2. Vellore Citizens' Welfare Forum v. Union of India (1996) 5 SCC 647 – Precautionary principle

Facts: The litigation concerned environmental pollution caused by industrial activities, particularly untreated tannery waste.

Judgment: The Supreme Court recognised the precautionary principle and polluter-pays principle as important components of Indian environmental law.

Relevance to digital pathogen governance:

The precautionary principle supports preventive action where scientific uncertainty exists but credible risks of serious harm are identified.

For example:

Authorities should not ignore credible warnings from pathogen-monitoring systems.

Laboratories should adopt preventive safeguards against biological risks.

Regulatory authorities should require appropriate risk assessments.

Uncertainty in algorithmic predictions should not become an excuse for ignoring serious biological threats.

3. K.S. Puttaswamy v. Union of India (2017) 10 SCC 1 – Right to privacy

Facts: The Supreme Court considered whether privacy is protected as a fundamental right under the Indian Constitution.

Judgment: The nine-judge Constitution Bench unanimously recognised privacy as a fundamental right under Article 21 and other constitutional freedoms.

Relevance:

Digital pathogen surveillance may involve sensitive health information, genomic information, and identifiable patient records.

Government agencies must therefore consider:

Lawful authority for collecting information.

Purpose limitation.

Data minimisation.

Security safeguards.

Proportionality of surveillance.

Protection against unauthorized disclosure.

The decision is particularly important where public-health surveillance threatens individual informational privacy.

4. Shreya Singhal v. Union of India (2015) 5 SCC 1 – Digital constitutional accountability

Judgment: The Supreme Court struck down Section 66A of the Information Technology Act, 2000, and examined intermediary liability and restrictions on online expression.

Relevance:

Digital pathogen information may be circulated through online platforms, scientific databases, and public communication systems.

The case supports the importance of:

Legality of digital restrictions.

Protection against arbitrary government action.

Clear statutory standards.

Constitutional limits on digital information control.

It does not directly determine pathogen-data liability, but offers useful principles for regulating digital information systems.

5. In Re: Distribution of Essential Supplies and Services During Pandemic (2021) – Public-health administration and accountability

Judgment: The Supreme Court examined the distribution of essential medical supplies, oxygen, medicines, and vaccination-related arrangements during COVID-19.

Relevance:

The proceedings illustrate that emergency public-health administration remains subject to judicial scrutiny.

Authorities responsible for digital disease-management systems should therefore maintain:

Transparent decision-making.

Reliable public-health information.

Rational allocation mechanisms.

Effective grievance procedures.

Accountability for administrative failures.

B. Digital disease surveillance: Kerala High Court's Sprinklr proceedings

6. Sprinklr COVID-19 data collection proceedings – Data protection and government accountability

During the COVID-19 pandemic, Kerala's use of the Sprinklr platform for processing health-related information raised questions about data security, confidentiality, anonymisation, and government accountability.

The Kerala High Court issued interim directions addressing safeguards for sensitive health information, including anonymisation and consent-related protections.

Legal significance:

This is particularly relevant because it concerns the actual use of a digital platform for disease-related data processing.

It demonstrates that:

Public-health emergencies do not eliminate privacy obligations.

Governments remain responsible for selecting and supervising technology providers.

Sensitive health information requires appropriate security safeguards.

Digital outsourcing does not automatically remove governmental accountability.

The proceedings should be distinguished from a final judgment establishing a general doctrine of pathogen-data liability.

C. International case laws

7. Jacobson v. Massachusetts (1905), 197 U.S. 11 – Public-health regulatory powers

Facts: The case concerned a compulsory smallpox vaccination requirement in Massachusetts.

Judgment: The US Supreme Court upheld the state's authority to adopt reasonable public-health measures, while recognising constitutional limits on the exercise of police powers.

Relevance:

The decision supports government authority to regulate biological risks, infectious diseases, and preventive health measures.

However, public-health powers must be exercised reasonably and cannot justify arbitrary or oppressive measures.

8. Big Brother Watch and Others v. United Kingdom (2021), Applications Nos. 58170/13, 62322/14 and 24960/15

Judgment: The European Court of Human Rights examined bulk interception of communications and the safeguards required for surveillance systems.

It emphasised end-to-end safeguards, including independent authorisation and effective oversight.

Relevance:

Digital pathogen surveillance systems may collect large volumes of personal and health information.

The decision provides useful principles concerning:

Independent supervision.

Protection against excessive surveillance.

Accountability throughout the data-processing lifecycle.

Effective safeguards against misuse.

It is not a pathogen-specific judgment, but its surveillance principles are relevant to digital epidemiological monitoring.

hudoc.echr.coe.int+1

9. Centrum för Rättvisa v. Sweden (2021), Application No. 35252/08

Judgment: The Court considered the compatibility of Sweden's bulk communications interception regime with Article 8 of the European Convention on Human Rights.

Relevance:

The case is relevant to cross-border pathogen-data governance because it addresses safeguards when intelligence information is transferred to foreign partners.

Its principles support:

Controls over international information sharing.

Effective review of surveillance activities.

Privacy safeguards.

Reasoned oversight decisions.

hudoc.echr.coe.int+1

10. Fabien Courtois and Others v. European Commission (Case T-761/21, 17 July 2024)

Facts: The litigation concerned access to documents relating to COVID-19 vaccine procurement contracts.

Judgment: The EU General Court examined the Commission's partial refusal to disclose documents, including the protection of personal data and commercial interests.

Relevance:

The judgment demonstrates the importance of balancing:

Public access to information.

Commercial confidentiality.

Privacy protection.

Transparency in emergency procurement.

These principles can be applied to digital pathogen platforms and public-private biotechnology partnerships.

EUR-Lex

5. Indian Legal Framework

India does not have one comprehensive statute specifically governing digital pathogen accountability. Several existing laws operate together.

Important institutional responsibilities

Indian Council of Medical Research (ICMR): Research standards and biomedical research ethics.

National Centre for Disease Control (NCDC): Disease surveillance and outbreak monitoring.

Department of Biotechnology (DBT): Biotechnology research and institutional oversight.

Indian Computer Emergency Response Team (CERT-In): Cybersecurity incident coordination and applicable reporting obligations.

National Biodiversity Authority (NBA): Relevant biological-resource access and benefit-sharing functions.

Accountability must be assessed according to each institution's statutory powers and actual role.

6. Australian Legal Framework

Australia provides an important comparative framework for digital pathogen governance because it regulates biosecurity risks, genetic technology, laboratory activities, and information security through different legal instruments.

A. Biosecurity Act 2015 (Cth)

The Biosecurity Act 2015 establishes a regulatory framework for managing biological threats, including diseases and pests that may enter or spread within Australia.

Its relevance includes:

Prevention and management of biological risks.

Regulatory control orders.

Monitoring and inspection powers.

Institutional responsibilities for managing biosecurity threats.

Civil penalties for specified statutory violations.

The legislation provides a foundation for accountability when biological threats are inadequately managed.

Federal Register of Legislation

B. Gene Technology Act 2000 (Cth)

The Gene Technology Act 2000 regulates dealings involving genetically modified organisms.

It establishes important oversight mechanisms involving the Gene Technology Regulator.

Its relevance to digital pathogen governance includes:

Oversight of regulated genetic technology activities.

Risk assessment and containment requirements.

Institutional responsibility for compliance.

Regulation of relevant genetically modified biological materials.

Not every digital pathogen database or pathogen-analysis platform falls within this Act. Its application depends on the regulated activity.

C. Privacy Act 1988 (Cth)

The Privacy Act 1988 regulates the handling of personal information by covered organisations and agencies.

The Australian Privacy Principles are particularly relevant to:

Collection of health information.

Disclosure to third-party technology providers.

Overseas data transfers.

Information security.

Access and correction rights.

D. Cybersecurity legislation

The Security of Critical Infrastructure Act 2018 may become relevant where pathogen-related digital infrastructure falls within a regulated critical infrastructure asset or sector.

The Privacy Act 1988 and applicable cybersecurity legislation can create overlapping responsibilities.

E. Relevant Australian case law

1. Marsh v Baxter [2015] WASCA 169

Facts: The dispute concerned contamination of an organic farming operation by genetically modified canola.

Legal significance: The Western Australian Court of Appeal considered negligence, causation, and the legal consequences of genetically modified crop contamination.

Relevance: It offers an analogy for disputes involving biological contamination and the responsibility of organisations managing potentially harmful biological activities.

It does not establish direct liability for digital pathogen failures.

2. Leatch v National Parks and Wildlife Service (1993) 81 LGERA 270

Legal significance: The case is associated with the application of precautionary reasoning in environmental decision-making where scientific uncertainty exists.

Relevance: Digital pathogen systems frequently produce uncertain predictions. Regulators should therefore assess the consequences of uncertainty rather than treating incomplete scientific evidence as proof that no risk exists.

7. International Legal Framework

Digital pathogen governance cannot be restricted to domestic legislation because pathogen information, biological research, and infectious diseases frequently cross national borders.

A. International Health Regulations (2005)

The International Health Regulations (2005) establish international obligations concerning the detection, assessment, notification, and response to public-health emergencies.

Their relevance includes:

National disease-surveillance capacities.

Timely reporting of qualifying public-health events.

International cooperation.

Public-health emergency preparedness.

Information exchange between states and WHO.

Digital disease surveillance can support these obligations, but the IHR do not independently establish a comprehensive liability regime for AI or digital pathogen platforms.

B. Biological Weapons Convention, 1972

The Biological Weapons Convention prohibits the development, production, acquisition, and stockpiling of biological agents and toxins for prohibited purposes.

Its relevance concerns institutional responsibility for preventing the misuse of biological research and technology.

C. Convention on Biological Diversity, 1992

The Convention on Biological Diversity provides a framework for biodiversity conservation, sustainable use, and fair and equitable benefit-sharing.

D. Nagoya Protocol, 2010

The Nagoya Protocol addresses access to genetic resources and benefit-sharing.

It may become relevant where pathogen-related biological material is accessed, exchanged, or used in research within its applicable scope.

Importantly, the legal treatment of digital sequence information is a developing international issue and should not be confused with the legal status of physical pathogen samples.

E. WHO Global Guidance Framework for the Responsible Use of the Life Sciences (2022)

The WHO framework promotes responsible life-sciences research, biosecurity awareness, institutional governance, and risk management.

It is a guidance instrument rather than a binding international liability convention.

8. Who Can Be Held Legally Accountable?

One of the most important aspects of this emerging doctrine is the allocation of responsibility among different actors.

Liability is not automatic. It depends on the applicable law, the existence of a duty, the nature of the breach, causation, and available statutory or contractual defences.

9. Major Forms of Legal Liability

A. Civil liability

Civil liability may arise when negligent pathogen management causes personal injury, economic loss, property damage, or other legally recognised harm.

For example, a laboratory fails to maintain appropriate safeguards, and a preventable biological incident causes injury.

Relevant principles include negligence, causation, duty of care, and compensation.

B. Criminal liability

Criminal responsibility may arise where conduct satisfies the elements of an applicable criminal offence.

Examples may include:

Intentional unlawful access to protected computer systems.

Deliberate concealment of legally reportable incidents.

Criminally prohibited biological activities.

Fraudulent falsification of research or regulatory records.

An ordinary algorithmic error is not automatically a criminal offence.

C. Administrative liability

Regulatory authorities may take action against organisations for violating applicable licence conditions, reporting requirements, biosafety rules, or cybersecurity obligations.

Possible consequences include suspension, cancellation of authorisations, civil penalties, corrective directions, and regulatory investigations.

D. Constitutional liability

In India, government decisions involving pathogen surveillance and digital health-data collection may be challenged under Articles 14, 19, and 21 of the Constitution, depending on the rights affected.

The legality, necessity, proportionality, and procedural fairness of state action are important considerations.

E. International responsibility

A state may incur international responsibility where conduct attributable to it breaches an applicable international obligation.

However, the failure of a private laboratory or technology company does not automatically create international responsibility for the state. Attribution and the relevant international legal obligation must be established.

10. Major Accountability Challenges

1. Algorithmic opacity: Regulators may be unable to understand how an AI system identified or classified a biological threat.

2. Unclear institutional responsibility: Multiple organisations may participate in pathogen-data collection, processing, and storage, making responsibility difficult to allocate.

3. Cross-border jurisdiction: A laboratory, cloud provider, data controller, and affected individual may be located in different countries.

4. Scientific uncertainty: Pathogen prediction systems may produce false positives and false negatives.

5. Commercial confidentiality: Companies may resist disclosing technical information necessary for independent investigation.

6. Delayed incident reporting: Failure to report a biological or cybersecurity incident promptly may increase the consequences of an emergency.

7. Privacy versus public health: Governments must balance disease surveillance with individual privacy and constitutional rights.

8. Lack of specialised judicial precedents: Courts have not yet developed a comprehensive body of decisions specifically addressing AI-driven pathogen governance.

11. Proposed Digital Pathogen Accountability Governance Model

A comprehensive accountability model should contain the following mechanisms.

A. Independent digital pathogen audits

High-risk digital pathogen systems should undergo independent audits covering data security, algorithmic reliability, institutional supervision, and regulatory compliance.

B. Human responsibility for automated decisions

Important decisions concerning biological risks should have identifiable human oversight.

An organisation should not escape responsibility simply by claiming that an AI system independently made the decision.

C. Mandatory accountability records

Research institutions should maintain appropriate records of:

System access and authorisation.

Risk assessments.

Security incidents.

Regulatory communications.

Significant algorithmic changes.

Human approvals.

Corrective actions.

D. International cooperation

India, Australia, and other countries should strengthen cooperation concerning pathogen-data sharing, cybersecurity incidents, laboratory safety, and cross-border public-health emergencies.

12. Critical Legal Issues for Future Development

The emerging doctrine raises several unresolved questions:

Can an AI developer be liable when an algorithm fails to detect a dangerous pathogen?

Should biotechnology companies face enhanced liability for failures involving high-risk biological research?

Can governments be held accountable for ignoring warnings generated by digital surveillance systems?

Who owns and controls internationally shared pathogen genomic information?

Should digital pathogen databases receive special cybersecurity protection?

Can individuals obtain compensation for harm caused by negligent digital disease surveillance?

Should independent regulators have mandatory access to proprietary pathogen-prediction algorithms?

How should liability be divided between laboratories, cloud providers, software developers, and public-health authorities?

These questions demonstrate the need for a specialised legal framework.

13. Relationship Between Digital Pathogen Governance and Other Legal Doctrines

14. Conclusion

Digital Pathogen Governance Accountability represents an important emerging area of biotechnology and public-health law.

Its central objective is to ensure that technological innovation does not weaken legal responsibility for biological safety, human rights, scientific integrity, and public-health protection.

The Indian Supreme Court's decisions in M.C. Mehta, Vellore Citizens' Welfare Forum, and K.S. Puttaswamy provide important foundations for developing this accountability framework. International decisions such as Big Brother Watch and Jacobson v. Massachusetts offer additional principles concerning surveillance safeguards and public-health powers.

Australia's Biosecurity Act 2015 and Gene Technology Act 2000 provide useful comparative regulatory models.

Ultimately, effective digital pathogen governance requires five fundamental principles:

Prevention: Biological and digital risks must be identified before serious harm occurs.

Transparency: Decisions involving pathogen-management technologies must be explainable and reviewable.

Responsibility: Every participating institution must have clearly allocated legal duties.

Accountability: Negligence, unlawful conduct, and regulatory violations must attract appropriate consequences.

Remedies: Individuals and communities affected by unlawful or negligent conduct must have access to effective legal remedies.

Final legal proposition: Digital pathogen governance must operate on the principle that technological delegation cannot become a method of escaping legal responsibility. Human institutions, governments, and corporations must remain accountable for the biological and digital risks arising from activities under their control.

15. Important References for Further Research

WHO – International Health Regulations

WHO – Responsible Use of the Life Sciences

India Code – Central Legislation

Australian Federal Register of Legislation

European Court of Human Rights – Case Law

COVID-19 Litigation Project – International Case Database

Academic qualification: Digital Pathogen Governance Accountability is a proposed doctrinal framework rather than a separately codified legal doctrine. The cases discussed above establish analogous principles; they should not be represented as direct judicial recognition of this specific doctrine.